Pegus Cheryl bought BSX
March 2, 2026 · Form 4 insider transaction
Pegus Cheryl bought 24 shares of Boston Scientific Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.; Deferred stock units granted in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $1,845.25, divided by the closing price of the common stock on the date of grant.